Zhejiang Novus Pharmaceuticals

Shaoxing, China Founded: 2015 • Age: 11 yrs Acquired By CTI BioPharma
Generic drugs, APIs, and dietary supplements are developed and manufactured.

About Zhejiang Novus Pharmaceuticals

Zhejiang Novus Pharmaceuticals is a Healthcare company based in Shaoxing (China) founded in 2015, and was acquired by CTI BioPharma in June 2003. Generic drugs, APIs, and dietary supplements are developed and manufactured. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.

Company details

Founded in 2015 as a subsidiary of Zhejiang Medicine, Novus Pharmaceuticals operates in the pharmaceutical sector from Shaoxing, China. Contract manufacturing is provided for soft gel capsules and generic drugs, alongside API production and dietary supplements in softgel and tablet formats. Generic products are planned, while API development and new drug molecules remain in the pipeline.

  • Headquarters Shaoxing, China
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website novuspharma.com
  • Acquired by CTI BioPharma (Jun 2003)
Key Metrics

Investors in Zhejiang Novus Pharmaceuticals

Zhejiang Novus Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include CTI BioPharma.

All
InvestorDescriptionFounded YearDomainLocation
Targeted small molecule therapeutics for blood cancers are developed.
1991ctibiopharma.comSeattle, United States
Premium access

Investor details for Zhejiang Novus Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Zhejiang Novus Pharmaceuticals

2 dated milestones of Zhejiang Novus Pharmaceuticals across 12 years, from founding to its latest funding, stage changes and deals.

  1. Exit Acquired by CTI BioPharma.
  2. Founded Zhejiang Novus Pharmaceuticals is founded.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Zhejiang Novus Pharmaceuticals

Zhejiang Novus Pharmaceuticals was founded in 2015.

Zhejiang Novus Pharmaceuticals is headquartered in Shaoxing, China. It is registered at Shaoxing, Zhejiang, China.

Founded in 2015 as a subsidiary of Zhejiang Medicine, Novus Pharmaceuticals operates in the pharmaceutical sector from Shaoxing, China. Contract manufacturing is provided for soft gel capsules and generic drugs, alongside API production and dietary supplements in softgel and tablet formats. Generic products are planned, while API development and new drug molecules remain in the pipeline.

Zhejiang Novus Pharmaceuticals has 1 investor. Key investors include CTI BioPharma.

Yes. Zhejiang Novus Pharmaceuticals was acquired by CTI BioPharma in June 2003.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available